Let's Talk ID

Three effective treatments for COVID-19 not (yet) in guidelines

03.25.2023 - By Infectious Diseases Society of America (IDSA)Play

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Paul Sax, MD, FIDSA and clinical trialist extraordinaire David Boulware, MD, MPH, FIDSA discuss promising studies of interferon lambda, metformin, and ensitrelvir for COVID-19 -- and why none of them is currently in treatment guidelines.

*This episode was recorded before the Paxlovid EPIC-SR results were released in an FDA briefing.

More episodes from Let's Talk ID